Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Insight Molecular Diagnostics Inc. (IMDX) vs Precipio, Inc. (PRPO)

Insight Molecular Diagnostics Inc. and Precipio, Inc. are both Diagnostics & Research companies. Insight Molecular Diagnostics Inc. is the larger, with a market value of $129.3M against $43.8M — 3.0× the size. Precipio, Inc. grew revenue faster over the last twelve months: 28.0% against −60.8%. Precipio, Inc. has the higher net margin (−4.47% vs −2,955.6%) and the lower return on invested capital (−7.63% vs 0.00%). Across the 17 metrics below, Precipio, Inc. leads on 12 and Insight Molecular Diagnostics Inc. on 5.

Valuation

Metric IMDX PRPO Diagnostics & Research median
P/E n/m n/m 33.95
P/S 86.26 1.55 4.87
P/B n/m 2.86 3.12
Price to free cash flow n/m 53.57 34.02
EV/EBITDA n/m 135.71 25.20
EV/Sales 75.74 1.48 5.66
Earnings yield (38.01%) (2.71%) (1.75%)
Free cash flow yield (21.52%) 1.87% (0.13%)

Profitability

Metric IMDX PRPO Diagnostics & Research median
Gross margin 48.32% 44.11% 50.89%
Operating margin (3,011.86%) (5.68%) (8.57%)
Net margin (2,955.63%) (4.47%) (6.37%)
Free cash flow margin (1,856.23%) 2.90% 0.00%
Return on equity 488.68% (8.98%) (2.92%)
Return on assets (123.46%) (6.05%) (6.71%)
Return on invested capital 0.00% (7.63%) 0.00%

Growth

Metric IMDX PRPO Diagnostics & Research median
Revenue growth (TTM) (60.77%) 28.04% 7.69%
EPS growth (last fiscal year) 64.59% 92.15% —
Revenue growth, 5-year CAGR 27.24% 31.60% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMDX PRPO Diagnostics & Research median
Debt to equity (0.04) 0.07 0.11
Current ratio 2.00 1.77 2.02
Net debt to EBITDA (0.67) (3.30) 0.78

Dividend

Metric IMDX PRPO Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric IMDX PRPO Diagnostics & Research median
Market cap 129.26m 43.81m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack